Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Nokukhanya Msomi"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) co-infection are significant public health issues, despite the availability of an effective HBV vaccine for nearly three decades and the great progress that has been m
Externí odkaz:
https://doaj.org/article/aca78af072704897bcef602f8469bcbb
Autor:
Lilishia Gounder, Andrew Tomita, Richard Lessells, Sandrini Moodley, Kerri-Lee Francois, Aabida Khan, Melendhran Pillay, Sontaga C Manyana, Subitha Govender, Kerusha Govender, Pravi Moodley, Raveen Parboosing, Nokukhanya Msomi, Frank Tanser, Kogieleum Naidoo, Benjamin Chimukangara
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 5, p e0003224 (2024)
South Africa rolled out dolutegravir (DTG) as first-line antiretroviral therapy (ART) in December 2019 to overcome high rates of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance. In the context of transition to DTG-based AR
Externí odkaz:
https://doaj.org/article/d67f1eec97dc4715a89305e9d69f3aa4
Autor:
Kerri-Lee A. Francois, Nokukhanya Msomi, Kerusha Govender, Lilishia Gounder, Pravi Moodley, Raveen Parboosing, Indrani Chetty, Lunga Xaba, Aabida Khan
Publikováno v:
African Journal of Laboratory Medicine, Vol 12, Iss 1, Pp e1-e6 (2023)
Background: KwaZulu-Natal ranked second highest among South African provinces for the number of laboratory-confirmed cases during the second wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The seroprevalence of SARS
Externí odkaz:
https://doaj.org/article/136ecb808a7249219fc9b41ef7e7d8bf
Autor:
Benjamin Chimukangara, Richard J. Lessells, Benn Sartorius, Lilishia Gounder, Sontaga Manyana, Melendhran Pillay, Lavanya Singh, Jennifer Giandhari, Kerusha Govender, Reshmi Samuel, Nokukhanya Msomi, Kogieleum Naidoo, Tulio de Oliveira, Pravi Moodley, Raveen Parboosing
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 468-475 (2022)
ABSTRACT: Objectives: In low–middle-income countries, increasing levels of HIV drug resistance (HIVDR) on second-line protease inhibitor (PI)-based regimens are a cause for concern given the limited drug options for third-line antiretroviral therap
Externí odkaz:
https://doaj.org/article/06c595bd500c4b65a557b119ab107495
Autor:
Nada Abdelatif, Inbarani Naidoo, Shanaaz Dunn, Mikateko Mazinu, Zaynab Essack, Candice Groenewald, Pranitha Maharaj, Nokukhanya Msomi, Tarylee Reddy, Benjamin Roberts, Khangelani Zuma
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundThe 2021 World Health Organization study on the impact of COVID-19 on older people (≥60 years) in the African region highlighted the difficulties they faced as the virus spread across borders and dominated the way of life. These difficult
Externí odkaz:
https://doaj.org/article/7d29a3012c144b96b4d87b3f06599173
Autor:
Cathrine Scheepers, Josie Everatt, Daniel G. Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni, Arshad Ismail, Boitshoko Mahlangu, Bronwen E. Lambson, Darren P. Martin, Eduan Wilkinson, James Emmanuel San, Jennifer Giandhari, Nelia Manamela, Noxolo Ntuli, Prudence Kgagudi, Sandile Cele, Simone I. Richardson, Sureshnee Pillay, Thabo Mohale, Upasana Ramphal, Yeshnee Naidoo, Zamantungwa T. Khumalo, Gaurav Kwatra, Glenda Gray, Linda-Gail Bekker, Shabir A. Madhi, Vicky Baillie, Wesley C. Van Voorhis, Florette K. Treurnicht, Marietjie Venter, Koleka Mlisana, Nicole Wolter, Alex Sigal, Carolyn Williamson, Nei-yuan Hsiao, Nokukhanya Msomi, Tongai Maponga, Wolfgang Preiser, Zinhle Makatini, Richard Lessells, Penny L. Moore, Tulio de Oliveira, Anne von Gottberg, Jinal N. Bhiman
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
The SARS-CoV-2 PANGO lineage C.1.2 has been under monitoring by global health authorities as it has spread worldwide. Here, Bhiman and colleagues characterise the emergence of the lineage, and its neutralisation sensitivity using data from vaccinees
Externí odkaz:
https://doaj.org/article/e365317a28774fd29c4b6a0f6a77a17a
Autor:
Nokukhanya Msomi, Kogieleum Naidoo, Nonhlanhla Yende-Zuma, Nesri Padayatchi, Kerusha Govender, Jerome Amir Singh, Salim Abdool-Karim, Quarraisha Abdool-Karim, Koleka Mlisana
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relati
Externí odkaz:
https://doaj.org/article/a75ea06cc11547e1bd4f21bc2f96172e
Autor:
Nokukhanya Msomi, Raveen Parboosing, Eduan Wilkinson, Jennifer Giandhari, Kerusha Govender, Benjamin Chimukangara, Koleka P. Mlisana
Publikováno v:
Viruses, Vol 14, Iss 4, p 788 (2022)
To understand the problem of persistent Hepatitis B virus (HBV) viraemia in HIV/HBV co-infected patients on HBV-active antiretroviral therapy (ART), we assessed the rate of HBV virological response in patients on HBV-active ART in KwaZulu-Natal, Sout
Externí odkaz:
https://doaj.org/article/0c38b161714e40109331d5a56914a20d
Autor:
Nokukhanya Msomi, Koleka Mlisana, Tulio de Oliveira, Carolyn Willianson, Jinal N. Bhiman, Dominique Goedhals, Susan Engelbrecht, Gert Van Zyl, Wolfgang Preiser, Diana Hardie, Marvin Hsiao, Nicola Mulder, Darren Martin, Alan Christoffels, Denis York, Jennifer Giandhari, Eduan Wilkinson, Sureshnee Pillay, Houriiyah Tegally, San Emmanuel James, Aquilah Kanzi, Richard John Lessells
Publikováno v:
The Lancet Microbe, Vol 1, Iss 6, Pp e229-e230 (2020)
Externí odkaz:
https://doaj.org/article/280876a1e16d4a879420d157da5bd9b8
Autor:
Tongai G Maponga, Montenique Jeffries, Houriiyah Tegally, Andrew Sutherland, Eduan Wilkinson, Richard J Lessells, Nokukhanya Msomi, Gert van Zyl, Tulio de Oliveira, Wolfgang Preiser
Publikováno v:
Clinical Infectious Diseases. 76:e522-e525
A 22-year-old woman with uncontrolled advanced human immunodeficiency virus (HIV) infection was persistently infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) beta variant for 9 months, the virus accumulating >20 additional m